A detailed history of Pflug Koory, LLC transactions in Amgen Inc stock. As of the latest transaction made, Pflug Koory, LLC holds 2,558 shares of AMGN stock, worth $716,419. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,558
Previous 2,558 -0.0%
Holding current value
$716,419
Previous $736,000 1.22%
% of portfolio
0.05%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

SELL
$218.65 - $271.46 $218 - $271
-1 Reduced 0.04%
2,558 $687,000
Q2 2023

Jul 21, 2023

BUY
$214.27 - $253.37 $50,996 - $60,302
238 Added 10.25%
2,559 $568,000
Q1 2023

Apr 20, 2023

SELL
$225.79 - $275.2 $10,160 - $12,384
-45 Reduced 1.9%
2,321 $561,000
Q3 2022

Oct 11, 2022

BUY
$224.46 - $253.15 $20,874 - $23,542
93 Added 4.09%
2,366 $533,000
Q2 2022

Aug 01, 2022

BUY
$230.71 - $256.74 $2,307 - $2,567
10 Added 0.44%
2,273 $553,000
Q1 2022

Apr 14, 2022

SELL
$219.27 - $242.57 $124,545 - $137,779
-568 Reduced 20.06%
2,263 $547,000
Q4 2021

Jan 20, 2022

BUY
$198.88 - $227.6 $144,983 - $165,920
729 Added 34.68%
2,831 $637,000
Q3 2021

Oct 19, 2021

SELL
$212.27 - $248.7 $136,065 - $159,416
-641 Reduced 23.37%
2,102 $447,000
Q2 2021

Jul 14, 2021

BUY
$233.58 - $259.14 $104,877 - $116,353
449 Added 19.57%
2,743 $669,000
Q3 2018

Nov 06, 2018

SELL
$185.29 - $208.89 $314,993 - $355,113
-1,700 Reduced 42.56%
2,294 $476,000
Q2 2018

Aug 13, 2018

BUY
$166.05 - $186.51 $282,285 - $317,067
1,700 Added 74.11%
3,994 $737,000
Q4 2017

Aug 13, 2018

BUY
$168.79 - $188.59 $25,318 - $28,288
150 Added 7.0%
2,294 $399,000
Q3 2017

Aug 13, 2018

BUY
$167.29 - $191.0 $8,364 - $9,550
50 Added 2.39%
2,144 $400,000
Q4 2016

Aug 13, 2018

BUY
N/A
2,094
2,094 $306,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pflug Koory, LLC Portfolio

Follow Pflug Koory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pflug Koory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pflug Koory, LLC with notifications on news.